US Patent 10988744 Method of producing alkaline phosphatase
Patent 10988744 was granted and assigned to Alexion Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+474 characters)
Article
Patent abstract
The disclosure provides a method of producing recombinant alkaline phosphatase comprising: (i) culturing an alkaline phosphatase in a recombinant cell culture; (ii) obtaining a preparation of recombinant alkaline phosphatase from the cell culture; and (iii) minimizing in the preparation a concentration of at least one metal ion selected from the group consisting of: Nickel (Ni), Cobalt (Co), Copper (Cu), Manganese (Mn), Chromium (Cr), and Molybdenum (Mo).
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Anne Kantardjieff0
Jared Davis0
Rachael Alford0
Saravanamoorthy Rajendran0
Sean Gallagher0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Edits on 23 Apr, 2023
Golden AI
Edits on 24 Sep, 2022
Golden AI
Infobox
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 10988744 Method of producing alkaline phosphatase
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10988744
Date of patent
April 27, 2021
Patent application number
16099310
Date Filed
June 6, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 10988744 Method of producing alkaline phosphatase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
